Copy For Citation
Sirmatel P., Yilmaz H., GÜNDÜZ E.
EUROPEAN JOURNAL OF THERAPEUTICS, vol.23, no.3, pp.106-110, 2017 (ESCI)
-
Publication Type:
Article / Article
-
Volume:
23
Issue:
3
-
Publication Date:
2017
-
Doi Number:
10.5152/eurjther.2017.66
-
Journal Name:
EUROPEAN JOURNAL OF THERAPEUTICS
-
Journal Indexes:
Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
-
Page Numbers:
pp.106-110
-
Keywords:
Lymphoma, autologous hematopoietic stem cell transplantation, non-malignant, late effect, BONE-MARROW-TRANSPLANTATION, HIGH-DOSE CHEMOTHERAPY, COMPLICATIONS, CHILDHOOD, SURVIVORS, HODGKIN, ADULTS
-
Eskisehir Osmangazi University Affiliated:
Yes
Abstract
Objective: Developments in transplantation procedures have led to an increase in the number of long-term survivors after hematopoietic stem cell transplantation (HSCT). In this study, we investigated non-malignant late side effects after autologous HSCT (AHSCT) in lymphoma patients.